Mastercard Inc
Change company Symbol lookup
Select an option...
MA Mastercard Inc
ABBV Abbvie Inc
BABA Alibaba Group Holding Ltd
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
VOLAF Volvo AB
AGNC Agnc Investment Corp
GME GameStop Corp
Go

Information Technology : IT Services | Large Cap Growth
Company profile

Mastercard Incorporated is a technology company that connects consumers, financial institutions, merchants, governments and businesses across the world, enabling them to use electronic forms of payment. The Company allows user to make payments by creating a range of payment solutions and services using its brands, which include MasterCard, Maestro and Cirrus. The Company provides a range of products and solutions that support payment products, which customers can offer to their cardholders. The Company's services facilitate transactions on its core network among account holders, merchants, financial institutions, businesses, governments and other organizations in markets globally. The Company's products include consumer credit, consumer debit, prepaid and commercial. It also provides integrated offerings such as cyber and intelligence products, information and analytics services, consulting, loyalty and reward programs and processing solutions.

Closing Price
$386.17
Day's Change
-0.32 (-0.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
389.10
Day's Low
383.67
Volume
(Average)
Volume:
2,725,766

10-day average volume:
2,817,748
2,725,766

Amid vaccine hurdles, EU battles to save summer vacations with COVID travel pass

9:22 am ET March 17, 2021 (MarketWatch)
Print

By Lina Saigol

Certificate would help governments coordinate travel measures as vaccination programs are rolled out across the bloc

The European Commission on Thursday proposed the creation of a COVID-19 certificate to allow European Union residents to travel more freely within the bloc, as it looks to boost the continent's battered tourism industry in time for summer.

That is even as the region struggles with its inoculation campaign, which has been comparatively slow compared with countries such as the U.S. and the U.K., as it has been plagued by repeated delivery delays amid manufacturing issues at some European plants.

The slowdown has been exacerbated by temporary suspensions in some European countries of use of the vaccine from drug company AstraZeneca , following reports of blood clots in some people who received shots.

Read: Germany and France become latest countries to halt use of AstraZeneca COVID-19 vaccine over blood clot concerns (https://www.marketwatch.com/story/astrazeneca-defends-covid-19-vaccine-after-more-countries-suspend-its-use-over-blood-clot-concerns-11615810632)

The digital green certificate would be granted to citizens who can prove they have been vaccinated, recently recovered from coronavirus disease, or have a negative coronavirus test, preventing the need for quarantines or travel bans.

"This certificate would facilitate safe free movement of citizens inside the EU during the COVID-19 pandemic in a nondiscriminatory way," said the Commission. "In addition to possible uses in healthcare, the aim of the certificate is to facilitate the safe free movement of citizens of one Member State to and in other EU Member States," it added.

(https://twitter.com/EU_Commission/status/1372107718857752576)

Countries including Greece, Spain and Portugal -- which are heavily reliant on tourism -- have been lobbying European governments to introduce a common system for travel to help governments coordinate travel measures as vaccination programs are rolled out across Europe.

However, some countries have also cautioned that digital health passes should not disadvantage people who have not yet been vaccinated. Greek Prime Minister Kyriakos Mitsotakis stated the country won't establish vaccination as a mandatory requirement for travel, but "those who have been vaccinated should be free to move."

The European Commission, the executive arm of the EU, has committed to vaccinating 70% of adults by the end of September. But its efforts have been hampered by repeated delivery delays, and more recently the suspension of the use of the AstraZeneca vaccine in several countries, including Germany, France and Spain, following reports of clotting issues in some recipients.

The European Medicines Agency, or EMA, said this week that there is "no indication" (https://www.marketwatch.com/story/sweden-halts-astrazeneca-vaccine-use-as-ema-says-no-indication-shot-causes-blood-clots-11615906213) that AstraZeneca's vaccine is the cause of reported blood clots, and reiterated that it remains "firmly convinced" that the benefits of the shot, which has been developed in collaboration with the University of Oxford, outweigh the risks.

The EMA, which is reviewing safety data, will comment again on Thursday after it has evaluated the latest information. Both France and Italy have signaled that they are prepared to restart the administration of the AstraZeneca vaccine if the regulator says the COVID-19 shot is safe.

Read: Airlines and travel stocks surge as U.K. sets out lockdown exit plans (https://www.marketwatch.com/story/airlines-and-travel-stocks-surge-as-u-k-sets-out-lockdown-exit-plans-11614080213)

The increasing availability of COVID-19 vaccines, including the one developed by Germany's BioNTech (BNTX) with its U.S. partner, drug company Pfizer (PFE), and the one made by U.S. biotech Moderna (MRNA), have prompted some governments to rethink travel restrictions, even amid a third wave of infections in Europe.

Several airlines, including IAG owned British Airways, American Airlines (AAL) and United Airlines (UAL), are trialing their own digital passes (https://www.marketwatch.com/story/united-airlines-trials-covid-19-health-pass-to-kick-start-global-travel-again-11603280283) to accelerate a safer opening of international borders and kick-start global travel, which has been hammered by the COVID-19 pandemic.

Read:American Airlines and British Airways trial free COVID testing on trans-Atlantic flights in boost to travel (https://www.marketwatch.com/story/united-airlines-trials-covid-19-health-pass-to-kick-start-global-travel-again-11603280283)

Global airline industry body IATA plans to launch its Travel Pass (https://www.iata.org/en/pressroom/pr/2020-11-23-01/) app at the end of March, which will manage and verify the secure flow of necessary testing or vaccine information among governments, airlines, laboratories and travelers.

Meanwhile, P&O Cruises, which is owned by Carnival (CCL), announced on Wednesday that British holidaymakers planning a "staycation cruise" will have to prove they have had two doses of a coronavirus vaccine. "Failure to provide proof, "will result in denial of boarding", P&O said in a statement (https://www.carnivalcorp.com/news-releases/news-release-details/po-cruises-offers-ultimate-escape-uk-holidays-summer-and) on Wednesday, adding that the requirement is a "strong expressed preference on the part of our guests."

-Lina Saigol; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

March 17, 2021 09:22 ET (13:22 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.